AAPP 2024 takes networking to new levels with daily opportunities to participate in a range of unique interactions with other attendees. Attendees may choose based on their availability, preferred type of networking, and practice-based interests. Networking events do not offer ACPE credit and are only available to in-person attendees in Orlando, Florida unless otherwise noted.
Take advantage of these opportunities to expand your network of colleagues and improve your practice.
*Will be live-streamed for virtual attendees.
Metabolic adverse effects are a well-known outcome associated with certain classes of psychotropic medications, especially second-generation antipsychotics. Patients with serious mental illnesses, such as schizophrenia and bipolar disorder, are known to have a reduced life expectancy due to an increased risk of physical co-morbidities, which may be exacerbated by the use of these agents. While data suggests that the benefits of antipsychotic use outweigh these risks, it is imperative to be able to identify and manage metabolic concerns that may arise to increase the likelihood of treatment compliance and subsequent decrease in symptom burden. This session will provide attendees with information regarding the incidence of psychotropic induced metabolic adverse effects, recommendations for metabolic monitoring intervals, and methods for incorporating metabolic management into a patient’s psychiatric treatment plan.
This session will offer a forum for those with any level of experience in monitoring and managing psychotropic induced metabolic adverse effects to share ideas and success stories, ask questions, and brainstorm solutions to challenges encountered in clinical practice. Finally, this session will provide attendees with a venue to collaborate with their colleagues to plan for creating a new metabolic management service or refining a service that they have already established.
Moderator/Speaker:
Session Materials:
Group therapy plays an important role in the overall treatment plan for patients with substance use disorders. Traditionally, group therapy programs, such as Alcoholics Anonymous (AA) or Narcotics Anonymous (NA), have been instrumental in helping to support long-term recovery. However, complete abstinence from substance use may not align with patients’ individual goals and return to use is common. Recognizing these challenges, the integration of harm reduction practices into group therapy sessions emerges as a strategy to reduce the risks associated with substance misuse and potentially saving lives. The core tenets of harm reduction emphasize the lived experience of the individual, allow for shared decision making, and meet the person’s needs.
The purpose of this idea exchange is to discuss ways to incorporate harm reduction practices into medication education groups. By the end of this presentation, we hope that pharmacists can discuss evidence-based harm reduction techniques, identify patients who would benefit from harm reduction education, and implement harm reduction principles into their daily practice. We will also share and discuss real world experiences, ethical dilemmas, and what could go wrong when discussing harm reduction in a group setting.
Moderator:
Speaker:
Artificial intelligence (AI) accessibility and use in education has increased since the release of Chat Generative Pre-Trained Transformer (ChatGPT) in 2022. The impact of AI specifically in pharmacy education is not yet known. AI has been viewed as a potential resource to assist in learning and a way to save time; however, there are concerns, such as academic integrity and retention of material with its use. It is necessary for pharmacy educators to be aware of the current landscape and capabilities of AI. The goal of this session is to increase understanding of AI, discuss experiences with AI, and share concerns with use of AI in didactic and experiential pharmacy education.
Moderators/Speakers:
Children and adolescents in foster care are likely to be prescribed high-risk psychotropic medication regimens. Not only are ~20% of youth in foster care prescribed at least one psychotropic medication, but they are four times as likely to be prescribed at least three psychotropic medications. BCPPs in child and adolescent psychiatry (CAP) are viewed as valuable members of the CAP team by foster care social workers, pediatricians, and child and adolescent psychiatrists. In addition to contributions to state-based guidelines supporting evidence-based prescribing in this population, many BCPPs in CAP serve this patient population daily in their clinical practice. The moderators will encourage participant engagement and sharing of unique experiences working with this pediatric population. The goal is for participants to acquire new ideas which can be incorporated into their clinical practice.
Moderators/Speakers:
Buprenorphine is an opioid that has been a well-known pharmaceutical agent since the mid 1900s. The Buprenex injectable buprenorphine was approved in 1985 but it wasn’t really until after the approval of Suboxone and Subutex in 2002 that buprenorphine really to become a gold standard treatment option for opioid use disorder. The recent opioid crisis has sprung buprenorphine into the spotlight as a powerful tool for risk reduction with important morbidity and mortality benefits. There are a multitude of different buprenorphine formulations that exist, creating a necessary pharmacist role in appropriate use of buprenorphine. This idea exchange will explore various buprenorphine products, highlight similarities and differences, and discuss methods to switch between buprenorphine products.
Moderator: Daniel Greer, PharmD, BCPP; Clinical Assistant Professor, Rutgers Ernest Mario School of Pharmacy; Piscataway, NJ
Speaker: Zoe Karavolis, PharmD, MPH, BCPP; Clinical Psychiatric Pharmacist, McLean Hospital; Belmont, MA
Session Materials:
Resident Program Directors have been faced with many points of discussion in light of the new ASHP residency standards effective July of 2023. Aspects of the newly published standard were presented at the AAPP 2023 RPD Idea Exchange and one year later, programs have been incorporating new practices and/or undergone accreditation surveys related to this new standard. During this idea exchange, points of discussion will include how programs have implemented the new standard with regard to the following: strategies for RPDs to promote and guide resident wellbeing; strategies to support preceptor wellbeing and prevent burnout (e.g., preceptor mentorship, etc.); preceptor development, including changes to the Academic and Professional Record (APR) and preceptor qualifications; and discussion on recruitment strategies (i.e., pivoting to virtual interviews, efforts to incorporate Diversity & Inclusion practices into recruitment). Discussion will be focused on sharing successful practices for introducing and implementing programmatic changes as well as brainstorming solutions to potential obstacles.
Moderator:
Speaker:
Session Materials:
While “wellbeing” and “preventing burnout” may sound like buzzwords associated with a shift in both clinician and healthcare trainee practices, data suggests that this shift is beneficial in not only reducing stress and the incidence of depressive symptoms and suicidal ideation, but in promoting lifelong resilience and healthy coping strategies. Both pharmacy residents and new practitioners alike benefit from integrating strategies to promote wellbeing and resilience into their daily work to reduce the risks to mental health. This session will provide attendees with information supporting resident and new practitioner mental health, including the development and execution of formal wellbeing activities as part of their facility’s residency program. This session will offer a forum for those with any level of experience with prioritizing resident and new practitioner wellbeing to share ideas, ask questions and brainstorm solutions to challenges encountered in your professional practice. Finally, this session will provide attendees with a venue to collaborate with their colleagues to create an actionable plan for prioritizing and incorporating wellness into their work life.
Moderators:
Speaker:
Session Materials:
Managing the mental health needs of older adult patients can be complicated by the presence of comorbid medical conditions. Drug-drug and drug-disease interactions, accompanied by the pharmacodynamic and pharmacokinetic changes that can occur as a patient ages, all contribute to elevating the complexity of managing this population. This panel discussion will engage community members to discuss challenges, strategies, and ideas around managing mental health conditions in older adults with medical comorbidities.
Moderators:
Speakers:
Session Materials:
Let’s engage in a crucial conversation about the impact of legislative changes that pose threats to vulnerable communities, impacting healthcare professionals and obstructing patients’ access to care. From imposing limitations on DEI programming to introducing legal ramifications for providers who offer care to LGBTQ+ patients; legislation exerts a top-down effect on healthcare at large. The shifting legislative landscapes across the nation introduce laws that challenge established healthcare principles, placing healthcare professionals in a difficult position. The question arises: how can we effectively navigate these challenges in healthcare delivery amidst continuously evolving legislative landscapes? It is imperative that we courageously bring these intricate conversations to the forefront. By directly acknowledging and addressing these issues, we cultivate an environment conducive to positive change, where inclusivity and equality can thrive, transcending geographical boundaries. The objective for this idea exchange is to evaluate the various legislative issues faced by healthcare professionals and generate innovative solutions, ensuring that the voices of marginalized communities are amplified.
Moderator:
Speaker:
Session Materials:
Sunday, April 7, 4:45 PM
The Judith J. Saklad Memorial Award celebrates the life and work of the late Judith J. Saklad. Dr. Saklad was Clinical Pharmacologist and Clinical Coordinator of Pharmaceutical Services at San Antonio State School and Clinical Assistant Professor of Pharmacy and Pharmacology at The University of Texas at Austin and the University of Texas Health Science Center at San Antonio. This award is presented annually to a senior psychiatric pharmacy practitioner who has achieved a level of professional distinction and demonstrates a continuing dedication to the practice of psychiatric pharmacy. AAPP is pleased to announce the recipient of the 2024 Judith J. Saklad Memorial Award, Vicki Ellingrod, PharmD, FCCP, FACNP. Dr. Ellingrod will accept the award on Sunday, April 7, following an afternoon of programming.
Vicki L. Ellingrod, PharmD, FCCP, FACNP, is the Dean of the College of Pharmacy at the University of Michigan and the John Gideon Searle Professor of Pharmacy. She is also a professor of Psychiatry and Psychology within the Medical School and College of Liberal Arts and Sciences. Within the University of Michigan, she serves as associate director of the Michigan Institute for Clinical and Health Research (MICHR), and principal investigator for the K12 program, which provides training and mentoring in translational research for health professionals and junior faculty. Those who nominated Dr. Ellingrod had this to say:
Sunday, April 7, 6:00 PM
Participate in discussions with the AAPP Board of Directors on issues critical to the profession and AAPP as an organization. The Board will update attendees on the highest priority issues and activities within the association while also providing the opportunity for participant questions and input. Following the Forum, the poster award winners will be announced!
Sunday, April 7, 6:15-7:15 PM
Join us for an evening of celebration to honor outgoing AAPP President Amy Werremeyer!
Although there is no scheduled session for viewing online posters, in-person and virtual attendees may view all posted poster PDFs at their convenience.
Monday, April 8, 5:45-7:15 PM, National BCD: Students, Pharmacists, and other Health Care Professionals
Tuesday, April 9, 4:30-6:00 PM, National BCD: Residents and Fellows
Two poster sessions round out the AAPP 2024 schedule on Monday and Tuesday evenings. During scheduled sessions, poster authors will be available at their posters to discuss the research and answer your questions.